Polymerase idling method for single molecule dna sequencing
US-2015132756-A1 · May 14, 2015 · US
US2016208318A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2016208318-A1 |
| Application number | US-201614991230-A |
| Country | US |
| Kind code | A1 |
| Filing date | Jan 8, 2016 |
| Priority date | Jun 5, 2009 |
| Publication date | Jul 21, 2016 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided herein are compositions and systems for use in polymerase-dependent, nucleotide transient-binding methods. The methods are useful for deducing the sequence of a template nucleic acid molecule and single nucleotide polymorphism (SNP) analyses. The methods rely on the fact that the polymerase transient-binding time for a complementary nucleotide is longer compared to that of a non-complementary nucleotide. The labeled nucleotides transiently-binds the polymerase in a template-dependent manner, but does not incorporate. The methods are conducted under any reaction condition that permits transient binding of a complementary or non-complementary nucleotide to a polymerase, and inhibits nucleotide incorporation.
Opening claim text (preview).
1 - 20 . (canceled) 21 . A method for identifying a nucleotide bound to a polymerase, comprising: transiently binding in a template-dependent manner, and without polymerizing, a first type of nucleotide to a first polymerase in the presence of a cation that inhibits nucleotide incorporation by the first polymerase, wherein the first polymerase is included in a first immobilized complex comprising (i) the first polymerase, (ii) a first template nucleic acid molecule, and (iii) a first polymerization initiation site, wherein the first immobilized complex is linked to a first site on a surface and the surface includes a plurality of immobilized complexes linked to other sites on the same surface wherein the first polymerase lacks exonuclease activity, and wherein the first type of nucleotide includes a detectable moiety; detecting the first type of transiently-bound nucleotide; and identifying the first type of transiently-bound nucleotide. 22 . The method of claim 21 , further comprising: removing the first type of nucleotide that is transiently bound to the first polymerase. 23 . The method of claim 22 , further comprising: contacting the first immobilized complex with a second type of nucleotide under suitable conditions for the first polymerase to polymerize the second type of nucleotide in a template-dependent manner. 24 . The method of claim 23 , further including polymerizing the second type of nucleotide using the first polymerase. 25 . The method of claim 23 , wherein the first type and second type of nucleotide are different types. 26 . The method of claim 23 , wherein the first type and second type of nucleotide are the same type. 27 . The method of claim 21 , wherein the detectable moiety of the first type of nucleotide includes a fluorescent label. 28 . The method of claim 21 , wherein the detectable moiety is linked to the base of the first nucleotide or linked to the terminal phosphate group of the first nucleotide. 29 . The method of claim 21 , wherein the first type of nucleotide includes an energy transfer acceptor moiety. 30 . The method of claim 21 , wherein the first polymerase includes an energy transfer donor moiety. 31 . The method of claim 21 , wherein the first nucleotide produces a FRET signal when transiently bound to the first polymerase. 32 . The method of claim 31 , wherein the FRET signal is optically detectable. 33 . The method of claim 21 , wherein the cation is present in a sufficient amount to inhibit incorporation of the first nucleotide by the first polymerase. 34 . The method of claim 21 , wherein the cation includes calcium, scandium, titanium, vanadium, chromium, iron, cobalt, nickel, copper, zinc, gallium, germanium, arsenic, selenium, rhodium, or strontium. 35 . The method of claim 21 , wherein the first polymerase comprises an RB69 polymerase, phi29 polymerase, B103 polymerase, or Klenow fragment polymerase. 36 . The method of claim 21 , wherein the first polymerase is an RB69 polymerase according to SEQ ID NO:5.
Methods for sequencing · CPC title
DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase · CPC title
involving interaction of two or more labels, e.g. resonant energy transfer · CPC title
involving mass spectrometry · CPC title
Screening for compounds of potential therapeutic value · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.